呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响

doi:10.16150/j.1671-2870.2019.03.002

摘要/Abstract

关键词: 慢性阻塞性肺疾病, 气道, 肠道, 微生物菌群, 机制

中图分类号:

R562.22

周敏, 张秋蕊. 呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响[J]. 诊断学理论与实践, 2019, 18(03): 246-249.

参考文献 35

[1]	Dickson RP, Erb-Downward JR, Martinez FJ, et al. The Microbiome and the Respiratory Tract[J]. Annu Rev Physiol, 2016, 78:481-504. doi: 10.1146/annurev-physiol-021115-105238 pmid: 26527186
[2]	Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways[J]. PLoS One, 2010, 5(1):e8578. doi: 10.1371/journal.pone.0008578 URL
[3]	Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD[J]. PLoS One, 2011, 6(2):e16384. doi: 10.1371/journal.pone.0016384 URL
[4]	Cabrera-Rubio R, Garcia-Nú? ez M, Setó L, et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease[J]. J Clin Microbiol, 2012, 50(11):3562-3568. doi: 10.1128/JCM.00767-12 pmid: 22915614
[5]	Mammen MJ, Sethi S. COPD and the microbiome[J]. Respirology, 2016, 21(4):590-599. doi: 10.1111/resp.12732 pmid: 26852737
[6]	Huang YJ, Kim E, Cox MJ, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbation[J]. OMICS, 2010, 14(1):9-59. doi: 10.1089/omi.2009.0100 URL
[7]	Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa[J]. Eur J Clin Microbiol Infect Dis, 2014, 33(7):1101-1111. doi: 10.1007/s10096-013-2044-0 URL
[8]	Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(10):1224-1231. doi: 10.1164/rccm.201302-0341OC URL
[9]	Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations[J]. Eur Respir J, 2016, 47(4):1082-1092. doi: 10.1183/13993003.01406-2015 URL
[10]	Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease[J]. J Clin Microbiol, 2014, 52(8):2813-2823. doi: 10.1128/JCM.00035-14 URL
[11]	Sze MA, Dimitriu PA, Suzuki M, et al. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease[J]. Am J Respir Crit Care Med, 2015, 192(4):438-445. doi: 10.1164/rccm.201502-0223OC URL
[12]	Charlson ES, Chen J, Custers-Allen R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers[J]. PLoS One, 2010, 5(12):e15216. doi: 10.1371/journal.pone.0015216 URL
[13]	Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers[J]. Am J Respir Crit Care Med, 2013, 187(10):1067-1075. doi: 10.1164/rccm.201210-1913OC URL
[14]	Benjamin JL, Hedin CR, Koutsoumpas A, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota[J]. Inflamm Bowel Dis, 2012, 18(6):1092-1100. doi: 10.1002/ibd.21864 pmid: 22102318
[15]	Biedermann L, Brülisauer K, Zeitz J, et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH[J]. Inflamm Bowel Dis, 2014, 20(9):1496-1501. doi: 10.1097/MIB.0000000000000129 pmid: 25072500
[16]	Kabeerdoss J, Jayakanthan P, Pugazhendhi S, et al. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid[J]. Indian J Med Res, 2015, 142(1):23-32. doi: 10.4103/0971-5916.162091 pmid: 26261163
[17]	Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285):59-65. doi: 10.1038/nature08821 URL
[18]	Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis[J]. Nat Rev Microbiol, 2017, 15(1):55-63. doi: 10.1038/nrmicro.2016.142 URL
[19]	Pistiner M, Gold DR, Abdulkerim H, et al. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy[J]. J Allergy Clin Immunol, 2008, 122(2):274-279. doi: 10.1016/j.jaci.2008.05.007 pmid: 18571710
[20]	Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment?[J]. J Allergy Clin Immunol, 2017, 139(4):1071-1081. doi: S0091-6749(17)30317-2 pmid: 28390574
[21]	He Y, Wen Q, Yao F, et al. Gut-lung axis: The microbial contributions and clinical implications[J]. Crit Rev Microbiol, 2017, 43(1):81-95. doi: 10.1080/1040841X.2016.1176988 URL
[22]	Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22):2355-2365. doi: 10.1056/NEJMra0800353 URL
[23]	Garmendia J, Morey P, Bengoechea JA. Impact of cigarette smoke exposure on host-bacterial pathogen interactions[J]. Eur Respir J, 2012, 39(2):467-477. doi: 10.1183/09031936.00061911 pmid: 21737564
[24]	Barnes PJ. Inflammatory endotypes in COPD[J]. Pharmacol Rev, 2004, 56(4):515-548. pmid: 15602009
[25]	Miyata R, van Eeden SF. The innate and adaptive immune response induced by alveolar macrophages exposed to ambient particulate matter[J]. Toxicol Appl Pharmacol, 2011, 257(2):209-226. doi: 10.1016/j.taap.2011.09.007 URL
[26]	Rylance J, Kankwatira A, Nelson DE, et al. Household air pollution and the lung microbiome of healthy adults in Malawi: a cross-sectional study[J]. BMC Microbiol, 2016, 16(1): 182. doi: 10.1186/s12866-016-0803-7 pmid: 27514621
[27]	Winter SE, B?umler AJ. Dysbiosis in the inflamed intestine: chance favors the prepared microbe[J]. Gut Microbes, 2014, 5(1):71-73. doi: 10.4161/gmic.27129 URL
[28]	Larsen JM, Musavian HS, Butt TM, et al. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology[J]. Immunology, 2015, 144(2):333-342. doi: 10.1111/imm.12376 pmid: 25179236
[29]	Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA[J]. Nature, 2000, 408(6813):740-745. doi: 10.1038/35047123 URL
[30]	Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells[J]. J Immunol, 2000, 164(2):944-953. pmid: 10623843
[31]	Kant R, de Vos WM, Palva A, et al. Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease[J]. J Med Microbiol, 2014, 63(Pt 2):293-308. doi: 10.1099/jmm.0.064220-0 URL
[32]	Reale M, Boscolo P, Bellante V, et al. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers[J]. Br J Nutr, 2012, 108(2):308-314. doi: 10.1017/S0007114511005630 URL
[33]	Sabra W, Kim EJ, Zeng AP. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures[J]. Microbiology, 2002, 148(Pt 10):3195-3202. doi: 10.1099/00221287-148-10-3195 URL
[34]	Tomoda K, Kubo K, Dairiki K, et al. Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice[J]. BMC Pulm Med, 2015, 15:64. doi: 10.1186/s12890-015-0059-2 URL
[35]	Hauptmann M, Schaible UE. Linking microbiota and respiratory disease[J]. FEBS Lett, 2016, 590(21):3721-3738. doi: 10.1002/1873-3468.12421 pmid: 27637588

呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[2]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[3]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[4]	孙娴雯, 李庆云. 新型冠状病毒疫情时期的慢性阻塞性肺疾病管理策略——2022版慢性阻塞性肺疾病全球倡议解读[J]. 诊断学理论与实践, 2022, 21(01): 32-37.
[5]	许飞, 尹明月, 王伟, 董治亚, 陆文丽, 余熠, 王歆琼, 王俊祺, 肖园. 性早熟女童肠道菌群和抗生素耐药性的宏基因组分析[J]. 诊断学理论与实践, 2022, 21(01): 52-61.
[6]	罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595.
[7]	苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433.
[8]	章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232.
[9]	董治亚, 戴彤彤. 肠道微生物群与儿童生长间相关性的研究进展及临床意义[J]. 诊断学理论与实践, 2021, 20(03): 234-238.
[10]	顾怡瑾, 李安琪, 董磊, 许海敏, 申霞, 谢嘉玲, 袁菲, 王朝夫. 原发、复发及转移胃肠道间质瘤KIT及PDGFRA突变与临床病理特征间的关系[J]. 诊断学理论与实践, 2021, 20(03): 257-264.
[11]	李林, 安静静, 王俊祺, 王歆琼, 董治亚. 16S rRNA第二代测序技术分析特发性身材矮小儿童肠道菌群构成的特征及相关发病机制研究[J]. 诊断学理论与实践, 2021, 20(02): 149-154.
[12]	李庆云, 孙娴雯. 慢性阻塞性肺疾病稳定期管理的几个新视点：2021版 GOLD指南解读[J]. 诊断学理论与实践, 2021, 20(01): 43-47.
[13]	李惠, 冯洁, 韩立中. 高通量测序技术分析无特定病原体级实验小鼠肠道的菌群组成[J]. 诊断学理论与实践, 2020, 19(1): 55-62.
[14]	康建强, 董杨阳, 杨玲, 宋珍, 范嘉盈. 下呼吸道流感嗜血杆菌定植对哮喘小鼠气道炎症的影响及信号通路的研究[J]. 诊断学理论与实践, 2020, 19(1): 44-49.
[15]	李庆云, 孙娴雯. 细化稳定期COPD管理流程和随访策略：2020版GOLD指南解读[J]. 诊断学理论与实践, 2020, 19(04): 354-358.